Medical Groups Challenge Government Order on Retail Medicine Prices in Malaysia

Seven medical groups and a Sabah-based general practitioner have filed for judicial review of a government order requiring private clinics to display retail medicine prices. The groups, representing over 10,000 medical professionals, argue that the order exceeds the minister's powers and threatens the integrity of medical practice. They contend that drug dispensation is part of treatment following consultation and diagnosis, not a commercial transaction akin to retail sales. The challenge also claims that small GP and specialist clinics would be unfairly disadvantaged due to higher costs and lower purchase volumes.

Key Takeaways:

• Seven medical groups, including the Association of Private Practitioners, Sabah (APPS), and the Malaysian Medical Association (MMA), have filed for judicial review of the government's order on retail medicine prices.
• The groups argue that the order exceeds the minister's powers, citing Section 10 of the Act, which they claim does not apply to medications administered during treatment.
• Medical and dental treatment is a regulated professional process governed by laws such as the Medical Act, Dental Act, and Poisons Act, not a commercial transaction akin to retail sales.
• The applicants note that drug labelling is already strictly regulated under PHFSA rules, which require proper labelling, storage, and documentation in both clinics and hospitals.
• The groups also warn that small GP and specialist clinics would be unfairly disadvantaged, as they cannot match pharmacy chains in pricing due to higher costs and lower purchase volumes.
• The applicants have asked the court to quash the order and stay enforcement pending the outcome of the case, citing potential irreversible harm from prosecutions if the order is later struck down.

Statistics:

• Over 10,000 medical professionals are represented by the seven medical groups challenging the government order.
• The order affects private clinics, which are expected to display retail medicine prices.
• Small GP and specialist clinics account for a significant portion of the affected medical professionals, with estimated higher costs and lower purchase volumes limiting their ability to match pharmacy chains in pricing.

Sources:

• HT Digital Content Services, Malay Mail, "Medical groups challenge government's order on retail medicine prices", published July 28 (without date of publication)
• Code Blue, "Eight medical groups file for judicial review of gov't order on retail medicine prices" (without date of publication)